An evaluation of animal models for using bioactive compounds in the treatment of inflammatory bowel disease
Abstract Inflammatory bowel disease (IBD) is a prevalent chronic relapsing‐remitting disease that affects the digestive tract and reduces patients’ quality of life. Food bioactive compounds are a promising approach for nutritional intervention of IBD with minimal side effects. To evaluate their pote...
Autores principales: | , , |
---|---|
Formato: | Artículo |
Lenguaje: | English |
Publicado: |
Wiley
2024-03-01
|
Colección: | Food Frontiers |
Materias: | |
Acceso en línea: | https://doi.org/10.1002/fft2.360 |